Few things today. First, one we haven’t chatted about for a while; enterprise infrastructure monitoring software firm Micromuse. We first mentioned this interesting company as a Trading Alert in February at $5.46. Currently flirting with $7, here’s the chart:
We could see this one head for $8 as a result of a nice thrusting move of late. Once, and if, it gets there we’ll have another look and assess.Still has nearly $140 million in cash and no debt.Looks like a decent company and has acted well so far.
In the shadow of Eden
Eden has been an exceptional trader so far. No reason to think that won’t continue. Here’s the tech stuff:
As before when we were down here, $5 is a critical support area. Bounced hard off of its .618 retracement and appears to want to do it again.While we wait for drilling and news in the fall, would be a buyer around $5 with tight stops, just in case. Traders might want to play the swings. There are lots of swings. Keeping an eye on developments through the fall.
Biocurex pulls back, again.
Here’s the chart:
Waiting for news of developments and the status of a more senior listing. Till then likely more of the same.
The recent down move has been a slow blood-letting on anaemic volume. Thursday, it rocked down hard on the same crappy volume. We believe that the stock as a result of boredom, some shorting and general lethargy has been in the process of cleaning out the weaklings over the last 6 weeks. Historically, these times have been good entry points as the bounces tend to return nicely in as little as a day. Not for the faint of heart.
Like the stock, like the story. There are obviously still a few challenges that won’t much matter in the future as the technology becomes more pervasive, Abbott eventually plays its cards and the company presents at the ISOBM conference later this month.
Trade Safely. Donate to the recovery effort. Now.
